Abbrea Capital’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $8.88M | Sell |
53,827
-651
| -1% | -$106K | 1.18% | 23 |
|
|
2024
Q1 | $8.84M | Sell |
54,478
-1,109
| -2% | -$174K | 1.16% | 23 |
|
|
2023
Q4 | $8.15M | Buy |
55,587
+200
| +0.4% | +$29.6K | 1.17% | 22 |
|
|
2023
Q3 | $8.08M | Sell |
55,387
-562
| -1% | -$85.8K | 1.28% | 22 |
|
|
2023
Q2 | $8.49M | Buy |
55,949
+228
| +0.4% | +$34.4K | 1.31% | 21 |
|
|
2023
Q1 | $8.29M | Sell |
55,721
-400
| -0.7% | -$57.2K | 1.41% | 18 |
|
|
2022
Q4 | $8.51M | Buy |
56,121
+728
| +1% | +$102K | 1.53% | 14 |
|
|
2022
Q3 | $6.99M | Sell |
55,393
-1,731
| -3% | -$246K | 1.32% | 16 |
|
|
2022
Q2 | $8.21M | Buy |
57,124
+150
| +0.3% | +$22.5K | 1.37% | 15 |
|
|
2022
Q1 | $8.71M | Buy |
56,974
+70
| +0.1% | +$11K | 1.22% | 19 |
|
|
2021
Q4 | $9.31M | Buy |
56,904
+1,736
| +3% | +$258K | 1.25% | 18 |
|
|
2021
Q3 | $7.71M | Sell |
55,168
-391
| -0.7% | -$55.4K | 1.15% | 20 |
|
|
2021
Q2 | $7.5M | Sell |
55,559
-75
| -0.1% | -$10.1K | 1.13% | 19 |
|
|
2021
Q1 | $7.53M | Sell |
55,634
-657
| -1% | -$85.7K | 1.24% | 17 |
|
|
2020
Q4 | $7.83M | Sell |
56,291
-402
| -0.7% | -$56.2K | 1.4% | 16 |
|
|
2020
Q3 | $7.88M | Buy |
56,693
+415
| +0.7% | +$55.1K | 1.67% | 14 |
|
|
2020
Q2 | $6.73M | Buy |
56,278
+1,131
| +2% | +$132K | 1.54% | 18 |
|
|
2020
Q1 | $6.07M | Sell |
55,147
-678
| -1% | -$81.4K | 1.61% | 18 |
|
|
2019
Q4 | $6.97M | Buy |
55,825
+451
| +0.8% | +$55.2K | 1.48% | 19 |
|
|
2019
Q3 | $6.89M | Buy |
55,374
+1,831
| +3% | +$216K | 1.59% | 18 |
|
|
2019
Q2 | $5.87M | Buy |
53,543
+19,733
| +58% | +$2.1M | 1.44% | 19 |
|
|
2019
Q1 | $3.52M | Buy |
33,810
+1,089
| +3% | +$106K | 1.01% | 32 |
|
|
2018
Q4 | $3.01M | Buy |
32,721
+21
| +0.1% | +$1.88K | 0.99% | 33 |
|
|
2018
Q3 | $2.72M | Sell |
32,700
-504
| -2% | -$41.2K | 0.8% | 37 |
|
|
2018
Q2 | $2.59M | Sell |
33,204
-2,477
| -7% | -$186K | 0.81% | 40 |
|
|
2018
Q1 | $2.83M | Sell |
35,681
-903
| -2% | -$75.3K | 0.92% | 35 |
|
|
2017
Q4 | $3.36M | Buy |
36,584
+1,866
| +5% | +$168K | 1.15% | 26 |
|
|
2017
Q3 | $3.16M | Sell |
34,718
-100
| -0.3% | -$9.1K | 1.17% | 21 |
|
|
2017
Q2 | $3.03M | Sell |
34,818
-1,380
| -4% | -$122K | 1.21% | 22 |
|
|
2017
Q1 | $3.25M | Buy |
36,198
+660
| +2% | +$58.5K | 1.33% | 18 |
|
|
2016
Q4 | $2.99M | Buy |
+35,538
| New | +$3.03M | 1.4% | 15 |
|
Other funds holding PG
Abbrea Capital's PG Position: Q2 2024 in Review
Abbrea Capital reduced its Procter & Gamble (PG) stake by 1.2% in Q2 2024, selling an estimated $106K and leaving 53,827 shares worth $8.88M. The position accounts for 1.18% of the portfolio, ranked #23.
Abbrea Capital first reported a position in PG in Q4 2016 and has held it in 31 quarters since. The position peaked at $9.31M in Q4 2021. 3,653 funds tracked by Wall St. Rank hold PG as of Q2 2024.
- Abbrea Capital held 53,827 shares of Procter & Gamble worth $8.88M as of Q2 2024.
- Abbrea Capital sold 651 Procter & Gamble shares in Q2 2024, an estimated $106K.
- Procter & Gamble made up 1.18% of Abbrea Capital's portfolio in Q2 2024, its #23 holding.
- Abbrea Capital first reported a position in Procter & Gamble in Q4 2016 and has held it in 31 quarters since.
- Abbrea Capital's Procter & Gamble position peaked at $9.31M in Q4 2021.
- 3,653 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2024.
Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.